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Since the first description of toxic shock syndrome 
(TSS) [ 11, a variety of clinical manifestations have been 
reported. A TSS-like syndrome designated recalcitrant 
erythematous desquamating (RED) disorder was 
described in patients with AIDS. FLED disorder has 
recently been described in a patient without AIDS [2], 
but, to our knowledge, not in children under 16 years 
old without AIDS. 
This study reports one case of a relapse of an 
erythematous desquamating disorder occurring 1 year 
after the first episode and involving the same toxin- 
producing Staphylococcus aureus strain, as confirmed by 
DNA fingerprinting with randomly amplified poly- 
morphic DNA (RAPD) analysis. 
Case reporf 
An otherwise healthy 9-year-old boy developed an 
urticaria-like eruption on the thorax with abdominal 
pain and conjunctivitis. He was treated with oxatomide. 
Fifteen days (day 15) later, the erythematous eruption 
covered the abdomen, perineum, thighs and arms 
and was accompanied by swelling and fissuring of the 
skin and fever of 39.5 O C .  Physical examination showed 
diffuse edematous tender erythema. Edema and super- 
ficial desquamation affected the hands, feet, lips and 
nostrils. There was pharyngeal inflammation and straw- 
berry tongue. Multiple inguinal and axillary nodes 
were observed. Examination of the conjunctiva revealed 
no abnormalities. The white blood cell count was 
38x109/L (with 46% eosinophils and 27% neutro- 
phils), the concentration of C-reactive protein (CRP) 
was 17 mg/L and the platelet count was 386 OOO/mm3. 
S h n  biopsy detected a perivascular lymphohistiocytic 
infiltrate containing a few neutrophils. The throat, 
nose and skin cultures produced a methicillin-sensitive 
S. auiws  strain. Antistaphylolysin antibodies were 
detected. The boy was given teicoplanin (10 mg/kg per 
day). ‘The white blood cell count 4 days after the 
beginrung of treatment (day 19) was 19 x109/L, with 
35% neutrophils and 37% eosinophils. There was no 
fever. Improvement of the pharyngitis and cutaneous 
lesions was evident at day 21. Teicoplanin was stopped 
and the boy was given oral oxacillin (50 mg/kg per 
day) for 5 days. 
Fourteen months later, he was referred for pharyn- 
gitis, with cervical lymph nodes. A scarlatiniform 
eruption appeared the next day with vesicles on 
the thigh and edema of the hand. There was a 
fever (38”C), CRP was <8 mg/L and the white cell 
count was 19x1Oy/L (with 69% neutrophds and 17% 
eosinophils). The platelet count was 375 OOO/mm3. 
The r e d t s  of the physical examination and the serum 
chemistry profde were normal. Culture ofsamples from 
the throat and nose again contained a methicillin- 
sensitive S. aureus strain, but skin culture remained 
sterile. The boy was given pristinamycin (3 g/day) for 
3 months. Cultures of samples h-om the throats of the 
parents were negative for S. aureus. 
We eliminated complement deficiency and func- 
tional impairment of granulocytes, and searched for 
immunodeficiency. Counts of T- and B-cells were 
normal (total lymphocytes 3105/mm3; o K T 3  60%, 
OKT4 34%, OKTs 32% and CDw 17%). Normal 
levels of immunoglobulin were present (IgE level was 
30g/L). The boy had a moderate IgG2 deficiency 
(0.40 g/L). The proliferation response in vitro to 
mitogens and specific antigens was normal. Study of the 
Vp repertoire showed no significant selective changes. 
We did not look for antibodies against toxin. 
The staphylococci isolated were identified as 
S. aureus by conventional methods. The two strains 
isolated from the throat during the first and the second 
episodes, had the same pattern of antimicrobial 
susceptibility: resistant to penicillin and sensitive to 
methicillin, aminosides, macrolides, tetracyclines, glyco- 
peptides, fusidic acid and co-trimoxazole. They both 
produced enterotoxin B (Professor Fleurette, Lyon, 
France) and carried the seb gene as determined by 
PCR. 
We studied the two isolates together with three 
epidemiologically unrelated strains of S. aureus by 
RAPD analysis to assess whether the two isolated 
strains were identical. Three PCR primers (5’GCC 
and 5’-TCACGATGCA-3’) were used for the RAPD 
procedure, which was adapted from that of Williams et 
al. [3] ,  :as previously described [4]. RAPD analysis 
generated four patterns for the five isolates with each 
primer. The two isolates recovered from the patient had 
CCCAC;GGGCACAGT-3’, 5’-AGTCAGCCAC-3’, 
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the same pattern, which differed from those of the 
unrelated strains (Figure 1) with the three different 
primers. 
DISCUSSION 
Superantigens are increasingly recognized as important 
etiologic factors in various human diseases. One of the 
i d l p t  superantigen families contains the various 
pyogenic (TSS toxin I and enterotoxin serotypes A, B, 
C, L l  and E) and exfoliatin toxins produced by S. 
uiireus. About half of all isolated strains of S. aurelrs 
produce enterotoxins, of which there are currently 
five (A-E) serologic types. Lehn et al. [5] reported that 
enterotoxin B is detectable in 7.7%) of the S. aureus 
strains that produce exotoxin. These toxins have 
been implicated in various diseases, including TSS, 
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staphylococcal scalded skin syndrome, food poisoning 
and RED disorder. They should be considered as 
potential causes of illnesses such as mucocutaneous 
lymph node syndrome (Kawasaki disease). These toxins 
cause T-cell proliferation regardless of the antigenic 
specificity of the T-cells. This results in the production 
of tumor necrosis factor and interleuhns 1 and 2 [6]. 
Cytohne intermediates also cause toxin-mediated 
erythema and desquamation. SEB (enterotoxin 8) also 
induces the release of substance P from the peripheral 
ends of sensory fibers, causing vasodilatation and 
histamine release from mast cells and other mediators 
[7]. This histamine release may explain the pruritus 
observed in our patient. 
Some of the clinical signs, such as fever, perineal 
rash with fissuring lips and peripheral extremity 
changes, are similar to those of Kawasaki disease. 
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Figure 1 Stilp/iylorocrits ntireitx fingerprintmg by RAPD. Lanes 1 and 3: unrelated strain5 from another patient. Lane 3: strain 
S I ; subject, first kolated strain. Lane 4: strain S2; subject, second isolated strain. Lanes 5, h and 7: unrelated strains from 
different rlrcas of France. 
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However, adolescent cases and recurrences of Kawasaki 
disease are rare [8].  The recurrence rate for Kawasaki 
dsease is also very low (0.6%). Multiple episodes 
of TSS, another toxin-mediated disease, are not 
uncommon, with recurrences in up to 32% of 
patients [9]. RED disorder characterized by erythema, 
desquamation, hypotension and fever is often recurrent 
in AIDS patients [lo]. Manders et al. [ll] described 
two cases of recurrent toxin-mediated perineal erythema 
in which the patients had a recurrent sore throat 
followed by perineal erythema. Thus, several features 
of our patient's illness are more consistent with more 
clinically benign recurrent toxin-mediated disease than 
with Kawasaki disease. The high level of eosinophrlia 
was surprising. The boy did not have a history of atopy 
or eczema, and the IgE level was normal. Eosinophilia 
may perhaps be induced by superantigen-mediated 
cytokines, particularly IL-4, due to the vigorous pro- 
liferative responses in lymphocytes. 
An inadequate antibody response to pyrogenic 
toxin has been reported in patients with TSS, and RED 
disorder has been suggested as a possible reason for the 
h g h  recurrence rate of that disorder [12]. We did not 
measure the titer of antibodies against enterotoxin B, 
but there were no signs of a deficiency in the antibody 
response in our patient. 
The two episodes occurring in a 1-year-period 
were caused by the same SEB-producing S. aureus 
strain, as shown by the RAPD analysis. Ths may be 
due to chronic carriage or reinfestation with the same 
strain. An alternative explanation is that the patient was 
a chronic carrier of this strain and that the presence of 
these isolates was an incidental finding not causally 
related to his manifestations. 
This type of repeat infection has not been 
described before. The RAPD method has the sim- 
plicity and rapidity of P C R  procedures. RAPD analysis 
of staphylococci for epidemiology is of value, because 
antimicrobial susceptibility does not differentiate 
between isolated strains, and phage typing has poor 
reproducibility and requires a large number of tests. 
CONCLUSION 
The recognized spectrum of toxin- and superantigen- 
related illnesses is expanding. Toxins are involved not 
only in severe diseases like TSS and Kawasaki hsease, 
but also in mild forms of toxin-mediated disease, such 
as our case. Recurrence has been reported in TSS, 
RED disorder and toxin-mediated recurrent perineal 
erythema, probably due to low levels of antibodies 
against bacterial toxins. In this study, we demonstrate 
that the same S. aureus strain was responsible for a 
recurrence of RED disorder after 1 year. 
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Enterococcus avium osteomyelitis 
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Eriterocorcrrs avium, has rarely been reported as a human 
pathogen. Having reviewed the literature, Patel et a1 
reported nine cases of E. aviirm bacteremia. These 
enterococcal bacteremia episodes were usually poly- 
microbial and associated with gastrointestinal diseases 
[ 1 ,?I. Recently a case of E. avirim bacteremia secondary 
to a venous thrombosis was described [3] .  
We can now report a case of E.  avium osteomyelitis 
with pyarthrosis of the right femur. To our knowledge, 
this is the first case of osteomyelitis with this pathogen. 
A 94-year-old man was hospitalized on 31 August 1996 
with fever and pain in the right thigh. A total hip joint 
had been implanted 10 years earlier, but was removed 
2 years ago due to instability. O n  admission, the 
radiologic examinations revealed signs of osteomyelitis 
in the upper part of the femur with a discrete 
pyarthrosis. C reactive protein (CRP) was elevated 
(81 mg/L; normal, less than 5 mg/L) but other labora- 
tory values were normal, including white blood cell 
counts. From the aspiration of the hip, E. avium was 
isolated which, though sensitive to penicillin G, amoxy- 
cillin, imipenem, erythromycin and ciprofloxacin, was 
resistant to cefazolin, ceftriaxone and netilmicin. The 
portal of entry remains unclear, but is probably gastro- 
intestinal. We found no echocardiographic evidence for 
endocarditis and all blood cultures remained sterile. 
Therapy with ciprofloxacin by mouth (500 mg b.d.) was 
initiated; this was followed by a progressive decrease in 
fever and pains until the patient could walk on crutches. 
He was dismissed on 29 September with ciprofloxacin 
by mouth (500 mg b.d.) and a slightly elevated C R P  
(31 mg/L). The patient was examined 14 weeks later 
on 29 January 1997; his general condition was good, 
without fever and pains and the CKP had returned to 
normal (5 mg/L). Since his dismissal from the hospital 
he has been living in a nursing home, and he can still 
walk on crutches. 
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